GlassScriptPhysician profile
Andrew L Apple
NPI 1639428154
$2,717.77
in general payments reported to CMS, 2019-2025
16 companies · $671 in 2025
The $671 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $451 · 2020: $188 · 2021: $311 · 2022: $297 · 2023: $508 · 2024: $292 · 2025: $671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,471.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $599.65 | 2019-2025 | Precision7, Dailies Total1, Rocklatan |
| Sun Pharmaceutical Industries INC. | $447.04 | 2019-2025 | Cequa, Xelpros |
| Biotissue Holdings INC. | $389.22 | 2020-2025 | |
| Allergan, INC. | $377.70 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $189.79 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Oyster Point Pharma, INC. | $169.54 | 2022-2024 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $125.00 | 2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $97.63 | 2019-2023 | |
| Kala Pharmaceuticals, INC. | $79.47 | 2021-2022 | |
| Shire North American Group INC | $64.73 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $39.90 | 2019-2023 | Acuvue |
| Abbvie INC. | $35.46 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $33.69 | 2019 | |
| Dompe US, INC. | $28.31 | 2022 | |
| Mallinckrodt Hospital Products INC. | $23.16 | 2025 | Acthar |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $17.48 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Apple listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.